Erectile Disorder, as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5-TR), is a condition characterized by a persistent or recurrent inability to achieve or maintain an adequate erection during sexual activity. This condition causes significant distress or interpersonal difficulty. It is important to note that the dysfunction cannot be better explained by a nonsexual mental disorder, severe relationship distress, significant stressors, or substance use, and it must not be attributable to the physiological effects of a substance or another medical condition (American Psychiatric Association [APA], 2023).

Individuals presenting with Erectile Disorder often report a consistent pattern of difficulty with erections that is either lifelong or acquired after a period of normal sexual functioning. The severity can vary, with some men able to achieve partial erections or only occasionally experiencing full erections, while others may be unable to achieve any erection at all. The distress caused by this condition is a crucial component, as it impacts the individual’s self-esteem, relationship dynamics, and overall quality of life. The experience of anxiety, worry, or avoidance of sexual encounters is common among those suffering from this disorder. Furthermore, the condition can have a significant impact on a partner's emotional and sexual satisfaction, potentially leading to strained relationships (Althof et al., 2013).

In understanding Erectile Disorder, it is essential to consider the complex interplay of physiological, psychological, and interpersonal factors. Research indicates that psychological factors such as performance anxiety, depression, and stress can significantly contribute to the disorder (Montorsi et al., 2006). Physical factors, including cardiovascular diseases, diabetes, and hormonal imbalances, play a critical role in developing and maintaining this condition (Shamloul & Ghanem, 2013).

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), outlines specific criteria for diagnosing Erectile Disorder (APA, 2023). According to the DSM-5-TR, the following criteria must be met for a diagnosis of Erectile Disorder:

• Persistent or Recurrent Inability to Attain or Maintain an Adequate Erection: The individual must experience persistent or recurrent difficulties in achieving or maintaining an erection sufficient for satisfactory sexual performance. This criterion emphasizes the consistent nature of the symptoms, which are not merely occasional or situational.
• Significant Distress or Interpersonal Difficulty: The erectile problems must cause significant distress or interpersonal difficulties for the individual. This criterion acknowledges the psychological and relational impact of the disorder beyond the physical symptoms.
• Not Better Explained by Another Mental Disorder: The symptoms are not better explained by another mental disorder (e.g., a depressive disorder), relational distress, or stressors.
• Not Attributable to Substance Use or Medical Conditions: The erectile dysfunction is not due to the physiological effects of a substance (e.g., a drug of abuse, medication) or another medical condition.

In the DSM-5-TR, specifiers for Erectile Disorder are used to provide additional detail about the individual's experience of the disorder. These specifiers help clinicians to more accurately describe the nature of the disorder in a particular individual, which can be essential for treatment planning and understanding the prognosis. The specifiers for Erectile Disorder are as follows:

• Lifelong vs. Acquired: This specifier differentiates between erectile dysfunction that has been present since the individual first became sexually active (lifelong) and erectile dysfunction that develops after a period of normal sexual function (acquired).
• Generalized vs. Situational: This specifier distinguishes between erectile dysfunction that occurs in all or almost all sexual situations (generalized) and erectile dysfunction that occurs in specific situations or with specific partners (situational).
• Due to Psychological Factors: This specifier is used when psychological factors are judged to be a significant cause of erectile dysfunction. It can be used in cases where the individual's psychological state, such as anxiety or depression, is the primary contributor to the disorder.
• Due to Medical Condition: This specifier indicates that erectile dysfunction is believed to be a direct physiological result of another medical condition. This might include diabetes, cardiovascular disease, or neurological disorders.
• Due to Mixed Factors: This is used when the erectile dysfunction is thought to be the result of a combination of both psychological factors and medical conditions.

These specifiers are crucial in the clinical setting as they provide a more comprehensive picture of the disorder, guiding clinicians in selecting the most appropriate treatment strategies. For example, understanding whether the disorder is lifelong or acquired can have significant implications for therapy, as can differentiating between psychological and medical causes. The use of specifiers thus enhances the precision and utility of the diagnosis of Erectile Disorder in the DSM-5-TR.

Research has further explored various aspects of these criteria. For instance, a study by Corona et al. (2016) highlighted the importance of considering both psychological and relational aspects when assessing the distress criterion, emphasizing that Erectile Disorder can significantly impact both areas. Moreover, Montorsi et al. (2006) provided evidence that erectile dysfunction is often a precursor to cardiovascular diseases, underscoring the necessity of ruling out medical conditions as part of the diagnostic process.

The DSM-5-TR criteria have been subject to clinical validation. A study by Rosen et al. (2014) assessed the DSM-5-TR criteria for sexual dysfunctions, including Erectile Disorder, and found that the criteria were generally applicable in clinical settings. However, the study also suggested further refinement in certain areas.

These criteria are meant to provide a comprehensive framework for diagnosing Erectile Disorder, ensuring that both the physical and psychological components of the disorder are adequately addressed. However, the complexity of Erectile Disorder, as highlighted in various studies, calls for a multifaceted approach in both diagnosis and treatment.

The Impacts

Erectile Disorder (ED) has multifaceted impacts on an individual's life, affecting psychological well-being, relationship dynamics, and overall quality of life. Research has extensively documented these impacts, highlighting the complex interplay between physical, psychological, and social factors.

Psychologically, ED can lead to feelings of embarrassment, a diminished sense of masculinity, and lowered self-esteem. A study by Nguyen et al. (2017) found that men with ED reported significantly higher levels of psychological distress, including symptoms of depression and anxiety, compared to those without ED. This psychological burden often exacerbates the condition, creating a cycle where anxiety about sexual performance hinders erectile function, which in turn increases anxiety.

The impact on relationships is also significant. According to a study by Fisher et al. (2005), ED can lead to decreased sexual satisfaction for both the individual and their partner, potentially straining the relationship. The study emphasized that sexual dysfunction in one partner can affect the other partner's sexual function and satisfaction, highlighting the relational nature of the disorder.

ED also affects the overall quality of life. A longitudinal study by Litwin et al. (2007) showed that men with ED had lower scores on health-related quality of life, including physical and emotional domains. These findings suggest that ED is not just a sexual health issue but also a broader health concern that can impact various aspects of life.

Additionally, ED has been linked to chronic health conditions. A meta-analysis by Gazzaruso et al. (2011) demonstrated a strong association between ED and cardiovascular diseases, suggesting that ED might be an early indicator of cardiovascular risk.

These studies collectively indicate that the impacts of ED are wide-ranging, affecting not only sexual function but also psychological health, relationships, and overall well-being. This underscores the importance of holistic approaches in the management and treatment of ED, addressing both the physical and psychosocial components of the disorder.

The Etiology (Origins and Causes)

The etiology of Erectile Disorder (ED) is multifactorial, involving a complex interplay of physiological, psychological, and environmental factors. Research over the years has identified several key contributors to the development and maintenance of ED.

Physiologically, vascular, hormonal, and neurogenic factors are prominent in the etiology of ED. A Selvin et al. (2007) study demonstrated that ED is strongly associated with cardiovascular diseases, suggesting vascular pathology is a critical factor. This association is primarily due to the impairment of blood flow, which is crucial for achieving and maintaining an erection. Hormonal imbalances, particularly low testosterone levels, have also been linked to ED. A study by Shabsigh et al. (2005) highlighted the role of testosterone in maintaining sexual desire and erectile function.

Neurogenic factors, including conditions that affect the nervous system, such as diabetes and multiple sclerosis, can also lead to ED. Burnett et al. (2008) explored how diabetes-induced neuropathy can impair the neural pathways necessary for an erection.

Psychological factors are equally important in the etiology of ED. Stress, anxiety, and depression are commonly associated with the onset and persistence of ED. A study by Rajkumar and Kumaran (2015) found that psychological stress and depression were significantly higher in men with ED compared to those without. Performance anxiety, in particular, creates a psychological barrier to sexual arousal and erection.

Lifestyle factors and certain medications can also contribute to ED. Smoking, excessive alcohol consumption, and a sedentary lifestyle are known risk factors. A study by Bacon et al. (2006) linked lifestyle factors, such as obesity and physical inactivity, to an increased risk of ED. Moreover, medications for hypertension, depression, and other conditions can have side effects that include ED.

These findings collectively suggest that ED is the result of an intricate interaction between physical health, psychological state, and lifestyle choices. Understanding the diverse etiological factors is crucial for developing effective treatment strategies for individuals with ED.

Comorbidities

Erectile Disorder (ED) is frequently associated with various comorbidities, encompassing both physical and psychological conditions. These comorbidities not only impact the severity and management of ED but also indicate broader health concerns.

Cardiovascular disease is one of the most significant comorbid conditions associated with ED. A landmark study by Montorsi et al. (2006) underscored the concept of ED as a predictor of cardiovascular events, noting the shared vascular pathology between ED and cardiovascular diseases. This study and others have highlighted the importance of cardiovascular assessment in men presenting with ED, as it might be an early indicator of atherosclerosis or other cardiovascular conditions.

Diabetes mellitus is another significant comorbidity. A study by Maiorino et al. (2015) found that men with diabetes are three times more likely to develop ED than men without diabetes. The study highlighted the role of endothelial dysfunction and neuropathy caused by diabetes in the development of ED. These findings suggest that ED in diabetic patients is not only a quality-of-life issue but also a marker of diabetic complications.

Psychological disorders, particularly depression and anxiety, are common comorbidities with ED. Rajkumar and Kumaran (2015) reported a significant association between ED and psychological conditions, emphasizing that the presence of ED can exacerbate the symptoms of depression and anxiety and vice versa. This interrelationship suggests that a multidisciplinary approach, addressing both psychological and physical aspects, is essential in managing ED.

Obesity and metabolic syndrome have also been linked with ED. A study by Esposito et al. (2004) demonstrated that men with metabolic syndrome had a higher prevalence of ED. This relationship is thought to be mediated by factors like insulin resistance, low-grade systemic inflammation, and endothelial dysfunction, all characteristic of metabolic syndrome and obesity.

Chronic kidney disease (CKD) and lower urinary tract symptoms (LUTS) are other notable comorbidities. A study by Rosen et al. (2012) highlighted the prevalence of ED in patients with CKD and LUTS, pointing towards shared pathophysiological mechanisms such as vascular and hormonal changes.

These studies collectively indicate that ED is often not an isolated condition but is linked with various other health issues. Recognizing and managing these comorbidities is crucial in the comprehensive care of patients with ED.

Risk Factors

Erectile Disorder (ED) is influenced by a variety of risk factors that can be broadly categorized into physiological, psychological, and lifestyle-related factors. These risk factors interplay to affect the incidence and severity of ED.

Physiologically, cardiovascular diseases and diabetes are significant risk factors for ED. A study by Montorsi et al. (2006) demonstrated a strong association between ED and cardiovascular conditions, suggesting that endothelial dysfunction and atherosclerosis play a critical role in the development of ED. Similarly, a study by Maiorino et al. (2014) found that diabetes significantly increases the risk of ED, likely due to the impact of hyperglycemia on vascular and neural functions.

Age is another major physiological risk factor. A large-scale study by Feldman et al. (1994) showed an apparent age-related increase in the prevalence of ED, with the condition becoming more common as men age. This increase is attributed to the cumulative effect of other health issues and a natural decline in sexual function over time.

Psychological factors such as stress, anxiety, and depression are also significant risk factors for ED. In their research, Rajkumar and Kumaran (2015) identified a strong correlation between psychological distress and ED, underscoring the impact of mental health on sexual function.

Lifestyle factors significantly influence the risk of developing ED. Smoking, alcohol consumption, and physical inactivity have been linked to an increased risk of ED. A study by Bacon et al. (2006) highlighted the role of these factors, showing that men who smoke or are overweight have a higher risk of ED. Additionally, medications for hypertension, depression, and other conditions can contribute to ED as a side effect, as noted in research by Shamloul and Ghanem (2013).

Collectively, these studies indicate that the risk factors for ED are diverse and often interconnected. Addressing these risk factors through lifestyle modifications and managing underlying conditions is a crucial component of preventing and treating ED.

Case Study

Background Information: Orson, age 52, is a financial analyst who has been married for 25 years.

Presenting Complaint: "I have been struggling with maintaining an erection for the past year."

History of Present Illness: Orson reports progressive difficulty in achieving and maintaining an erection sufficient for sexual intercourse over the past year. He describes these issues as being more pronounced over the last six months. He notes that these difficulties are present regardless of the situation or partner, causing significant distress in his marital relationship. Orson denies any previous episodes of similar nature. He also reports experiencing a decreased libido.

Past Medical History: Orson was diagnosed with type 2 diabetes mellitus and hypertension three years ago. He is currently on metformin and a calcium channel blocker. He has a history of moderate smoking for the past 30 years but quit smoking two years ago. There is no significant history of surgeries or other chronic illnesses.

Psychosocial History: Orson is a father of two and has been experiencing moderate levels of stress at work. He denies any history of mental health issues but admits feeling increasingly anxious about his sexual performance. He consumes alcohol socially and does not use any recreational drugs.

Examination and Findings:

• Physical Examination: Generally healthy appearance; vital signs within normal limits; physical examination unremarkable except for mild obesity.
• Psychological Assessment: Exhibits signs of mild anxiety, particularly concerning sexual performance; no signs of major depression or other mental health disorders.
• Laboratory Tests: Normal complete blood count and lipid profile; HbA1c slightly elevated; testosterone levels at the lower end of the normal range.

Assessment: Orson meets the DSM-5-TR criteria for Erectile Disorder. His condition is acquired, generalized, and likely due to medical and psychological factors. His diabetes and hypertension are significant contributors, and the anxiety related to his sexual performance is exacerbating his condition.

Treatment Plan:

• Medical Management: Referral to a urologist for further evaluation and management of ED in the context of diabetes and hypertension. Discussion of potential pharmacological interventions such as PDE5 inhibitors.
• Psychological Intervention: Referral to a psychologist for counseling to address performance anxiety and provide coping strategies.
• Lifestyle Modification: Dietary consultation for better glycemic control and weight management. Encouragement to continue abstaining from smoking and to maintain moderate alcohol consumption.
• Follow-Up: Regular follow-up appointments to monitor response to treatment and adjust management plans as necessary.

Prognosis: With appropriate medical and psychological interventions, along with lifestyle modifications, there is a potential for improvement in Orson’s erectile function and overall quality of life. Continuous monitoring of his diabetes and hypertension is crucial for long-term management.

Recent Psychology Research Findings

Psychological research has provided significant insights into Erectile Disorder (ED), exploring its psychological underpinnings, the impact on mental health, and the effectiveness of psychological interventions.

One key area of research focuses on the psychological factors contributing to ED. A study by McCabe and Althof (2014) examined the role of psychological factors, such as performance anxiety, depression, and stress, in the development and maintenance of ED. They found that psychological distress, particularly related to performance anxiety, was a significant predictor of ED, suggesting that interventions targeting these psychological aspects could be beneficial.

Another important research topic is the impact of ED on mental health and quality of life. A comprehensive study by Shabsigh et al. (2008) explored the relationship between ED and depression, finding a bidirectional association where ED increased the risk of depression and vice versa. This study highlighted the need for a holistic approach to treating ED, considering both sexual function and overall mental health.

Cognitive-behavioral therapy (CBT) has been a focal point of research in psychological interventions for ED. A randomized controlled trial by Melnik et al. (2007) compared the effectiveness of CBT to sildenafil (a pharmacological treatment for ED). The study found that while both treatments were effective, CBT had the added benefit of improving self-esteem and reducing performance anxiety, underlining the importance of addressing psychological factors in ED treatment.

Research on couple-based interventions for ED has also been notable. A study by McCabe (2001) investigated the efficacy of couple-based psychological interventions and found significant improvements in sexual satisfaction and erectile function. This research underscores the value of involving partners in the therapeutic process, emphasizing the relational aspect of ED.

Lastly, the impact of lifestyle modifications on the psychological aspects of ED has been studied. A research study by Esposito et al. (2004) examined the effects of lifestyle changes on ED and found that weight loss, increased physical activity, and a healthier diet led to improvements in erectile function and psychological well-being.

These studies collectively demonstrate the complex interplay between psychological factors and ED. They emphasize the importance of integrating psychological approaches into the treatment of ED to address not only the physical symptoms but also the psychological and relational aspects of the disorder.

Treatment and Interventions

The treatment and intervention strategies for Erectile Disorder (ED) are diverse, encompassing pharmacological, psychological, and lifestyle modification approaches. Research has extensively evaluated these treatments, providing evidence for their effectiveness.

Pharmacological treatments, particularly Phosphodiesterase type 5 inhibitors (PDE5i), are the most common and well-researched intervention for ED. A comprehensive meta-analysis by Hatzimouratidis et al. (2010) assessed the efficacy and safety of PDE5 inhibitors, including sildenafil, tadalafil, and vardenafil. They found these medications to be highly effective in enhancing erectile function across various etiologies of ED, with a favorable safety profile. However, they are unsuitable for all patients, particularly those with certain cardiovascular conditions.

Intracavernous injection therapy is another pharmacological option, where vasoactive substances are injected directly into the penis. A study by Porst et al. (1999) found this therapy effective, especially in cases where PDE5 inhibitors are contraindicated or ineffective. However, it requires proper training and carries a risk of side effects like priapism (prolonged erections).

Vacuum erection devices, which create an erection by creating a vacuum around the penis, followed by constriction to maintain the erection, are a non-invasive option. A study by Lewis and Witherington (1997) demonstrated their effectiveness and acceptability to patients, especially those who prefer a non-pharmacological approach.

Psychological interventions, particularly cognitive-behavioral therapy (CBT), have been found effective, especially for ED with a significant psychological component. Melnik et al. (2007) conducted a study comparing CBT with sildenafil, finding that while both were effective, CBT additionally improved self-esteem and reduced performance anxiety.

Lifestyle modifications, including weight loss, increased physical activity, and a healthier diet, have also improved erectile function. A randomized controlled trial by Esposito et al. (2004) found that these changes led to significant improvements in ED and were associated with improved cardiovascular health.

Combined therapies using pharmacological, psychological, and lifestyle approaches are increasingly recognized for their effectiveness. A study by Rastrelli et al. (2013) showed that combining PDE5 inhibitors with psychological counseling produced better outcomes than medication alone, especially in cases with a psychogenic component.

These studies illustrate the range of available treatments for ED, each with its own set of advantages and considerations. Treatment selection should be individualized, considering the patient's condition, preferences, and overall health.

Implications if Untreated

Leaving Erectile Disorder (ED) untreated can have significant implications, affecting not only sexual health but also overall physical and psychological well-being.

One of the primary implications of untreated ED is a decrease in quality of life. A study by Althof (2002) emphasized the profound impact ED can have on self-esteem and happiness. The study highlighted that men with untreated ED often experience feelings of inadequacy, low self-esteem, and decreased life satisfaction, which can extend to their interpersonal relationships.

The impact on relationships is another crucial consideration. According to a study by Fisher et al. (2005), ED can lead to diminished sexual satisfaction and may cause strain in relationships. The study found that the partner's sexual satisfaction and the overall quality of the relationship were negatively impacted in couples where ED was not addressed.

Untreated ED has also been linked with the worsening of mental health conditions. A research study by Shabsigh et al. (2008) found a bidirectional relationship between ED and depression, suggesting that ED can exacerbate symptoms of depression, and depressive symptoms can, in turn, worsen ED. This cyclical relationship underlines the importance of treating ED to break this cycle and improve mental health outcomes.

In addition to psychological implications, untreated ED can have physical health consequences. ED is often associated with underlying medical conditions, such as cardiovascular diseases and diabetes. A study by Montorsi et al. (2006) suggested that ED could be an early marker of cardiovascular disease, indicating that untreated ED might overlook a critical opportunity for early intervention and management of cardiovascular risk.

Furthermore, a lack of treatment for ED can lead to avoidance of healthcare services for related conditions. A study by Miner et al. (2012) indicated that men with untreated ED were less likely to engage in health-seeking behaviors, potentially leading to the progression of comorbid conditions.

These studies collectively demonstrate that untreated ED can have wide-ranging and significant implications, affecting psychological well-being, relationship dynamics, and physical health. Therefore, addressing ED is crucial not only for restoring sexual function but also for enhancing overall health and quality of life.

Summary

Erectile Disorder (ED) presents significant challenges in diagnosis and management, reflecting its complex nature and profound impact on individuals' lives. Historically, perspectives on ED have evolved considerably, shifting from a predominantly physiological understanding to a more holistic view that encompasses psychological, relational, and lifestyle factors.

Initially, ED was often viewed through a narrow biomedical lens, focusing primarily on physical causes and treatments. However, over time, there has been a growing recognition of the psychological and social dimensions of ED. Research by Althof (2002) and Shabsigh et al. (2008) underscores the intricate interplay between ED and mental health, particularly the links with self-esteem, depression, and anxiety. This evolution in understanding has led to more inclusive and compassionate approaches to diagnosis and treatment, considering the individual's psychological and relational context.

The relational impact of ED is profound. Studies by Fisher et al. (2005) and McCabe (2001) have highlighted how ED can disrupt intimate relationships, affecting not only the individual with the disorder but also their partner. The disorder can lead to decreased sexual satisfaction and strained communication, potentially causing relationship breakdowns if not adequately addressed.

Furthermore, ED can profoundly affect personal identity and daily functioning. The sense of masculinity and sexual competence is often intertwined with sexual performance, and ED can challenge these aspects of identity. This can lead to decreased confidence and self-worth, as highlighted by Althof (2002), and can extend into other areas of life, affecting social interactions and professional performance.

The challenges in diagnosing ED arise from its multifaceted nature and the stigma associated with sexual health issues. There is often a reluctance to seek help due to embarrassment, which can delay diagnosis and treatment. The historical stigmatization of ED has decreased over time, thanks in part to public awareness campaigns and more open discussions in the medical community and media.

Erectile Disorder is a complex condition with multifaceted challenges in diagnosis and management. Its impact extends beyond physical symptoms, affecting psychological well-being, identity, relationships, and overall quality of life. The evolution in understanding ED reflects a more empathetic and holistic approach, recognizing the need for comprehensive care that addresses physical, psychological, and relational aspects.

References

Althof, S. E. (2002). Quality of life and erectile dysfunction. Urology, 59(6), 803-810.

Althof, S. E., Rosen, R. C., Perelman, M. A., & Rubio-Aurioles, E. (2013). Standard operating procedures for taking a sexual history. Journal of Sexual Medicine, 10(1), 26–35.

Bacon, C. G., Mittleman, M. A., Kawachi, I., Giovannucci, E., Glasser, D. B., & Rimm, E. B. (2006). A prospective study of risk factors for erectile dysfunction. Journal of Urology, 176(1), 217-221.

Burnett, A. L., Strong, T. D., Trock, B. J., Jin, L., Bivalacqua, T. J., & Musicki, B. (2008). Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. Journal of Urology, 179(1), 245–250.

Corona, G., Rastrelli, G., Limoncin, E., Sforza, A., Jannini, E. A., & Maggi, M. (2016). Interplay between premature ejaculation and erectile dysfunction: A systematic review and meta-analysis. Journal of Sexual Medicine, 13(12), 1743-1751.

Esposito, K., Giugliano, F., Di Palo, C., Giugliano, G., Marfella, R., D'Andrea, F., ... & Giugliano, D. (2004). Effect of lifestyle changes on erectile dysfunction in obese men. JAMA, 291(24), 2978-2984.

Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994). Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. Journal of Urology, 151(1), 54-61.

Fisher, W. A., Rosen, R. C., Eardley, I., Sand, M., & Goldstein, I. (2005). Sexual experience of female partners of men with erectile dysfunction: The female experience of men's attitudes to life events and sexuality (FEMALES) study. Journal of Sexual Medicine, 2(5), 675–684.

Gazzaruso, C., Giordanetti, S., De Amici, E., Bertone, G., Falcone, C., Geroldi, D., ... & Solerte, S. B. (2011). Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation, 114(21), 2125-2130.

Hatzimouratidis, K., Amar, E., Eardley, I., Giuliano, F., Hatzichristou, D., Montorsi, F., ... & Salonia, A. (2010). Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. European Urology, 57(5), 804–814.

Lewis, R. W., & Witherington, R. (1997). External vacuum therapy for erectile dysfunction: Use and results. World Journal of Urology, 15(1), 78–82.

Litwin, M. S., Nied, R. J., & Dhanani, N. (2007). Health-related quality of life in men with erectile dysfunction. Journal of General Internal Medicine, 22(3), 292-297.

Maiorino, M. I., Bellastella, G., & Esposito, K. (2014). Diabetes and sexual dysfunction: Current perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 95-105.

McCabe, M. (2001). Psychological factors and the sexuality of aging men and women. Journal of Sex Research, 38(3), 223–228.

McCabe, M. P., & Althof, S. E. (2014). A systematic review of the psychosocial outcomes associated with erectile dysfunction: Does the impact of erectile dysfunction extend beyond a man's inability to have sex? Journal of Sexual Medicine, 11(2), 347–363.

Melnik, T., Soares, B. G., & Nasello, A. G. (2007). The effectiveness of psychological interventions for the treatment of erectile dysfunction: Systematic review and meta-analysis, including comparisons to sildenafil treatment. Journal of Sexual Medicine, 4(4 Pt 2), 1036-1051.

Miner, M., Billups, K. L., & Nehra, A. (2012). The role of the primary care clinician in the management of erectile dysfunction. Reviews in Urology, 14(1), 1-10.

Montorsi, F., Adaikan, G., Becher, E., Giuliano, F., Khoury, S., Lue, T. F., ... & Sharlip, I. (2006). Summary of the recommendations on sexual dysfunctions in men. Journal of Sexual Medicine, 1(1), 6–23.

Nguyen, H. M., Gabrielson, A. T., & Hellstrom, W. J. (2017). Erectile dysfunction in young men—A review of the prevalence and risk factors. Sexual Medicine Reviews, 5(4), 508–520.

Porst, H., Buvat, J., Meuleman, E., Michal, V., Wagner, G., & Zeelenberg, M. (1999). Intracavernous Alprostadil Alfadex—an effective and well-tolerated treatment for erectile dysfunction. Results of a long-term European study. International Journal of Impotence Research, 11(3), 119-128.

Rajkumar, R. P., & Kumaran, A. K. (2015). Depression and anxiety in men with sexual dysfunction: A retrospective study. Comprehensive Psychiatry, 60, 114-118.

Rastrelli, G., Boddi, V., Corona, G., Mannucci, E., Petrone, L., De Vita, G., ... & Maggi, M. (2013). Psychological aspects in the assessment and treatment of erectile dysfunction in aging men. Sexual Medicine Reviews, 1(1), 24-36.

Rosen, R. C., Cappelleri, J. C., Smith, M. D., Lipsky, J., & Peña, B. M. (2014). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research, 16(6), 442–450.

Rosen, R. C., Catania, J. A., Althof, S. E., Pollack, L. M., Peiper, C., & Rupp, L. (2012). Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology, 79(5), 1006-1012.

Selvin, E., Burnett, A. L., & Platz, E. A. (2007). Prevalence and risk factors for erectile dysfunction in the US. American Journal of Medicine, 120(2), 151-157.

Shabsigh, R., Klein, L. T., Seidman, S., Kaplan, S. A., Lehrhoff, B. J., & Ritter, J. S. (2008). Increased incidence of depressive symptoms in men with erectile dysfunction. Urology, 72(5), 1174-1178.

Shabsigh, R., Rajfer, J., Aversa, A., Traish, A. M., Yassin, A., Kalinchenko, S. Y., & Buvat, J. (2005). The evolving role of testosterone in the treatment of erectile dysfunction. International Journal of Clinical Practice, 59(9), 1089–1098.

Shamloul, R., & Ghanem, H. (2013). Erectile dysfunction. The Lancet, 381(9861), 153-165.